Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, V. S.
Right arrow Articles by Flanigan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, V. S.
Right arrow Articles by Flanigan, M.
J Am Soc Nephrol 14:2297-2304, 2003
© 2003 American Society of Nephrology

Insulin Is Protein-Anabolic in Chronic Renal Failure Patients

Victoria S. Lim*, Kevin E. Yarasheski{dagger}, Jan R. Crowley{dagger}, Jerry Fangman* and Michael Flanigan*

*Departments of Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and {dagger}Washington University Medical School, St. Louis, Missouri.

Correspondence to Dr. Victoria S. Lim, Department of Medicine, University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, Iowa 52242. Phone: 319-356-3415; Fax: 319-384-8220;

ABSTRACT. To examine the protein anabolic actions of insulin in chronic renal failure, the authors measured four sets of whole body leucine fluxes during insulin alone and insulin with amino acid infusion in nine uremic patients before hemodialysis (B-HD). Seven were restudied 8 wk after initiation of maintenance hemodialysis (HD). Six normal subjects served as control (N). All values (µmol/kg/h, mean ± SEM) are presented in the sequence of B-HD, HD, and N, and only P < 0.05 are listed. During Flux 1 (baseline), D (leucine release from body protein degradation) were 114 ± 7, 126 ± 4, and 116 ± 6, respectively. C (leucine oxidation rates) were 18 ± 2, 17 ± 2, and 21 ± 3, respectively. S (leucine disappearance into body protein [index of protein synthesis]) were 96 ± 6, 107 ± 4, and 94 ± 4, respectively, and balances (net leucine flux into protein [values were negative during fasting]) were -18 ± 2, -17 ± 2, and -21 ± 3, respectively. During Flux 2 (low-dose insulin infusion), D were 89 ± 3, 98 ± 6, and 94 ± 5, respectively; C were 12 ± 1, 11 ± 2, and 18 ± 1, respectively (P = 0.02); S were 77 ± 4, 87 ± 5, and 76 ± 5, respectively, and balances were -12 ± 1, -11 ± 2, and -18 ± 1, respectively (P = 0.02). During Flux 3 (high-dose insulin infusion): D were 77 ± 3, 82 ± 7, and 84 ± 5, respectively; C were 9 ± 1, 8 ± 1, and 14 ± 1, respectively (P = 0.005); S were 68 ± 4, 74 ± 6, and 70 ± 5, respectively, and balances were -9 ± 1, -8 ± 1, and -14 ± 1, respectively (P = 0.005). In Flux 4 (insulin infused with amino acids): D were 73 ± 3, 107 ± 18, and 85 ± 7, respectively; C were 35 ± 4, 29 ± 5, and 39 ± 3, respectively; S were 105 ± 5, 145 ± 15, and 113 ± 6, respectively (P = 0.02), and balances were 32 ± 4, 38 ± 5, and 27 ± 3, respectively. These data show that B-HD and HD patients were as sensitive as normal subjects to the protein anabolic actions of insulin. Insulin alone reduced proteolysis and leucine oxidation, and insulin given with amino acids increased net protein synthesis. E-mail: victoria-lim@uiow.edu




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. W. Lee, G. H. Park, S. W. Lee, J. H. Song, K. C. Hong, and M.-J. Kim
Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2554 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. S. C. Raj, O. Adeniyi, E. A. Dominic, M. A. Boivin, S. McClelland, A. H. Tzamaloukas, N. Morgan, L. Gonzales, R. Wolfe, and A. Ferrando
Amino acid repletion does not decrease muscle protein catabolism during hemodialysis
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1534 - E1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. A. Ikizler and J. Himmelfarb
Muscle Wasting in Kidney Disease: Let's Get Physical
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2097 - 2098.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
G. R. Adams and N. D. Vaziri
Skeletal muscle dysfunction in chronic renal failure: effects of exercise
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F753 - F761.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
N. J. M. Cano, D. Fouque, and X. M. Leverve
Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure
J. Nutr., January 1, 2006; 136(1): 299S - 307S.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. S. Lim, T. A. Ikizler, D. S.C. Raj, and M. J. Flanigan
Does Hemodialysis Increase Protein Breakdown? Dissociation between Whole-Body Amino Acid Turnover and Regional Muscle Kinetics
J. Am. Soc. Nephrol., April 1, 2005; 16(4): 862 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Deshmukh, B. G. Phillips, T. O'Dorisio, M. J. Flanigan, and V. S. Lim
Hormonal responses to fasting and refeeding in chronic renal failure patients
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E47 - E55.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673